Cold plasma as a potential adjunctive therapy in COVID-19: report of three cases

Cold plasma as a potential adjunctive therapy in COVID-19: report of three cases Fahimeh Abdollahimajd1,2, Mohammad Reza Pourani1*, Alireza Fatemi,3 Hamideh Moravvej1*1 Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran;2 Clinical Research Development Unit, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran3 Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran*Corresponding author: Hamideh Moravvej, Skin Research Center, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Tel: +98- 21-22741507, Fax:+98-2122744392, Email: hamidehmoravej@sbmu.ac.ir* Co-corresponding author: Mohammad Reza Pourani, Skin Research Center, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Tel: +98- 21-22741507, Fax:+98-2122744392, Email: mreza.pourani92@gmail.comWord count: 595 Number of references: 5Items: 2 FiguresKeywords: Cold plasma, COVID-19, Coronavirus 2019, TreatmentRunning title: COVID-19 infection and cold plasma treatmentFunding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Competing Interests: The authors declare no conflict of interest.